Scholars Central

ArticlePublished 20 May 2024

Current management of aneurysmal hemodialysis arteriovenous fistulas: Brief review

Authors: Kirran Bakhshi, Ayman Ahmed

Interventional Cardiology

Volume 16 · Issue 2 · Pages 838–840

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chronic Kidney Disease (CKD) affects over 15% of adults in the United States, as estimated by the Center of Disease Control and Prevention in 2021. End-stage renal disease is the final and irreversible stage of kidney failure which requires renal replacement therapy. The growth in end-stage renal disease and the relative paucity of transplantable kidneys means that the need for dialysis access is significant. In 2020, only about 20,000 patients received an organ out of over 90,000 patients on the waiting list for a kidney in the United States. For those who didn’t receive a kidney, many patients opt for hemodialysis. The prevailing theory of ‘fistula first’ persists, due to reported improved outcomes with fistulas compared to grafts, such as improved patency. There are however known chronic difficulties with fistulas, including aneurysmal degeneration, thrombosis or stenosis, infection, or steal syndrome. The aim of this review article is to go over current available management modalities for aneurysmal hemodialysis arteriovenous fistula and to discuss advantages and disadvantages of each modality based on the available literature.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Kirran Bakhshi”
  • BylineArticles whose byline prints “Ayman Ahmed”